These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 10320044

  • 1. Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the 'a' epitope of the surface antigen are sensitive to ganciclovir.
    Oon CJ, Chen WN, Lim N, Koh S, Lim GK, Leong AL, Tan GS.
    Antiviral Res; 1999 Apr; 41(3):113-8. PubMed ID: 10320044
    [Abstract] [Full Text] [Related]

  • 2. Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy.
    Lee SY, Choi MS, Lee D, Lee JH, Koh KC, Paik SW, Yoo BC.
    J Korean Med Sci; 2005 Jun; 20(3):433-7. PubMed ID: 15953865
    [Abstract] [Full Text] [Related]

  • 3. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O, Benhamou Y, Cahour A, Katlama C, Poynard T, Thibault V.
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [Abstract] [Full Text] [Related]

  • 4. Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus.
    Wakil SM, Kazim SN, Khan LA, Raisuddin S, Parvez MK, Guptan RC, Thakur V, Hasnain SE, Sarin SK.
    J Med Virol; 2002 Nov; 68(3):311-8. PubMed ID: 12226816
    [Abstract] [Full Text] [Related]

  • 5. Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.
    Mutimer D, Pillay D, Cook P, Ratcliffe D, O'Donnell K, Dowling D, Shaw J, Elias E, Cane PA.
    J Infect Dis; 2000 Feb; 181(2):713-6. PubMed ID: 10669360
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.
    Bartholomew MM, Jansen RW, Jeffers LJ, Reddy KR, Johnson LC, Bunzendahl H, Condreay LD, Tzakis AG, Schiff ER, Brown NA.
    Lancet; 1997 Jan 04; 349(9044):20-2. PubMed ID: 8988118
    [Abstract] [Full Text] [Related]

  • 7. New amino acid changes in drug resistance sites and HBsAg in hepatitis B virus genotype H.
    Fernández-Galindo DA, Sánchez-Ávila F, Bobadilla-Morales L, Gómez-Quiróz P, Bueno-Topete M, Armendáriz-Borunda J, Sánchez-Orozco LV.
    J Med Virol; 2015 Jun 04; 87(6):985-92. PubMed ID: 25732900
    [Abstract] [Full Text] [Related]

  • 8. Wild-type and 'a' epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigen and antibody.
    Mesenas SJ, Chow WC, Zhao Y, Lim GK, Oon CJ, Ng HS.
    J Gastroenterol Hepatol; 2002 Feb 04; 17(2):148-52. PubMed ID: 11966944
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients.
    Seta T, Yokosuka O, Imazeki F, Tagawa M, Saisho H.
    J Med Virol; 2000 Jan 04; 60(1):8-16. PubMed ID: 10568756
    [Abstract] [Full Text] [Related]

  • 12. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy.
    Chayama K, Suzuki Y, Kobayashi M, Kobayashi M, Tsubota A, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Murashima N, Ikeda K, Kumada H.
    Hepatology; 1998 Jun 04; 27(6):1711-6. PubMed ID: 9620347
    [Abstract] [Full Text] [Related]

  • 13. [A study on mutations of the overlapping hepatitis B virus surface and polymerase gene in patients with HBV reinfection after liver transplantations].
    Song HL, Shen ZY, Wang J, Zheng WP, Wang ZL.
    Zhonghua Gan Zang Bing Za Zhi; 2008 Apr 04; 16(4):265-9. PubMed ID: 18423147
    [Abstract] [Full Text] [Related]

  • 14. Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India.
    Kazim SN, Sarin SK, Sharma BC, Khan LA, Hasnain SE.
    Intervirology; 2006 Apr 04; 49(3):152-60. PubMed ID: 16428891
    [Abstract] [Full Text] [Related]

  • 15. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group.
    Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, Brown N, Condreay LD.
    Hepatology; 1998 Jun 04; 27(6):1670-7. PubMed ID: 9620341
    [Abstract] [Full Text] [Related]

  • 16. High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates.
    Neumann-Fraune M, Beggel B, Pfister H, Kaiser R, Verheyen J.
    J Med Virol; 2013 May 04; 85(5):775-9. PubMed ID: 23408582
    [Abstract] [Full Text] [Related]

  • 17. Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene.
    Torresi J, Earnest-Silveira L, Civitico G, Walters TE, Lewin SR, Fyfe J, Locarnini SA, Manns M, Trautwein C, Bock TC.
    Virology; 2002 Jul 20; 299(1):88-99. PubMed ID: 12167344
    [Abstract] [Full Text] [Related]

  • 18. Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment.
    Moriconi F, Colombatto P, Coco B, Ciccorossi P, Oliveri F, Flichman D, Maina AM, Sacco R, Bonino F, Brunetto MR.
    J Antimicrob Chemother; 2007 Aug 20; 60(2):341-9. PubMed ID: 17567633
    [Abstract] [Full Text] [Related]

  • 19. Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants.
    Suzuki F, Akuta N, Suzuki Y, Sezaki H, Arase Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kobayashi M, Matsuda M, Satoh J, Watahiki S, Kumada H.
    J Med Virol; 2006 Mar 20; 78(3):341-52. PubMed ID: 16419116
    [Abstract] [Full Text] [Related]

  • 20. Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine.
    Tatti KM, Korba BE, Stang HL, Peek S, Gerin JL, Tennant BC, Schinazi RF.
    Antiviral Res; 2002 Jul 20; 55(1):141-50. PubMed ID: 12076758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.